Lipocine
LPCN
#9573
Rank
NZ$45.77 M
Marketcap
$8.56
Share price
6.16%
Change (1 day)
106.46%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: NZ$45.77 Million

As of November 2024 Lipocine has a market cap of NZ$45.77 Million. This makes Lipocine the world's 9573th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$45.77 M95.19%
2023NZ$23.45 M-57.71%
2022NZ$55.45 M-56.71%
2021NZ$0.12 B3.47%
2020NZ$0.12 B475.4%
2019NZ$21.51 M-48.91%
2018NZ$42.11 M-58.98%
2017NZ$0.10 B5.83%
2016NZ$97.01 M-71.85%
2015NZ$0.34 B301.28%
2014NZ$85.89 M-32.46%
2013NZ$0.12 B

End of Day market cap according to different sources

On Nov 21st, 2024 the market cap of Lipocine was reported to be:

NZ$47.14 Million
by Nasdaq info icon info icon
NZ$45.77 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$73.87 B 161,285.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.94 B 28,182.74%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$17.84 M-61.01%๐Ÿ‡บ๐Ÿ‡ธ USA